Business Context and Reporting Period
This Form 8-K filing by IRADIMED CORP (IRMD) was submitted on July 16, 2020, reporting events occurring on July 15, 2020. The filing addresses the departure of a senior officer and the terms of his separation agreement.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on personnel changes and contractual agreements.
Material Changes
The primary material change reported is the retirement of Louis Waldman, the Company's Controller. A Separation Agreement was executed on July 15, 2020, effective through his retirement date of July 24, 2020.
Guidance, Outlook, and Management Commentary
The filing details the specific compensatory arrangements for Mr. Waldman's retirement:
- Service Period: Continued service as Controller until July 24, 2020.
- Bonus: Eligibility for the 2020 annual performance bonus on a prorated basis.
- Time Off: A one-time addition of 120 hours to his paid time-off balance.
- Health Insurance: Company-paid coverage through November 30, 2020.
- Equity: Accelerated vesting of all unvested restricted stock units, totaling 5,155 shares of common stock.
- Covenants: Restrictive covenants from his September 18, 2018, Employment Agreement remain in effect.
No forward-looking guidance, risk factors, or unusual items were disclosed in this report.
Investor Verification Checklist
- Verify the impact of the Controller's departure on the Company's internal financial controls and reporting timeline.
- Confirm the total number of shares issued upon the accelerated vesting of 5,155 RSUs and any associated dilution.
- Review the full text of the Separation Agreement (Exhibit 10.1) for any additional non-disclosed terms.
- Monitor subsequent filings for the appointment of a new Controller or interim replacement.